Archive: 2026/04
FDA Bioequivalence Standards for NTI Drugs: Understanding Special Requirements
Posted by Ellison Greystone on Apr, 4 2026
Explore the strict FDA bioequivalence standards for Narrow Therapeutic Index (NTI) drugs, including the 90-111% limits and the scaled average bioequivalence approach.